Bannister, Robin Mark,Brew, John,Stoloff, Gregory Alan
申请号：
AU2016219596
公开号：
AU2016219596B2
申请日:
2016.08.24
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
#$%^&*AU2016219596B220180301.pdf#####ABSTRACT [0222] A pharmaceutical composition comprising a cancer therapeutic that is capable of inhibiting and/or reducing the ability of a cancer cell to take up and utilize glucose or other energy source, a lipid or other building block of a cell membrane or organelle, and/or cholesterol. The pharmaceutical composition can comprise one or more cancer therapeutics that can be administered individually or in combination to an individual.
